Health ❯ Obesity

Weight Management

Medications Pharmaceuticals Dietary Interventions Treatment Options Pharmaceutical Treatments Lifestyle Changes Medication Drug Treatments Dietary Strategies Pharmaceutical Interventions Weight Loss Treatments Pharmacotherapy Diet Programs Drug Development Comorbidities GLP-1 Drugs Dietary Solutions Weight Loss Medications Drug Efficacy Health Risks Dietary Supplements Caloric Restriction Weight-Loss Drugs BMI Guidelines Drug Trials Hormonal Effects Genetics Dietary Medications Metabolic Disorders Weight Loss Programs Dietary Patterns Body Fat Percentage Hormonal Regulation Hormonal Influence Bariatric Procedures Medication Side Effects Weight Loss Drugs Food Choices Exercise Benefits Pharmacological Treatments Dietary Approaches Dietary Changes Reality TV Caloric Intake Stigma Reduction Weight-loss Drugs Eating Disorders Weight-loss Treatments Medication Use Metabolic Health Healthcare Access GLP-1 Agonists Medication Effects Anti-Obesity Medications Appetite Control Chronic Diseases Clinical Research Medical Interventions GLP-1 Treatments Body Composition Behavioral Interventions Weight Loss Interventions Bariatric Alternatives Cardiovascular Health Interventions Exercise Therapeutic Approaches Medical Treatments Diet Plans Surgical Interventions Stigma Health Initiatives Non-injectable Treatments Injectable Therapies Clinical Trials GLP-1 Medications Weight Loss Strategies GLP-1 Receptor Agonists Gender Differences Cold Exposure Weight-loss Injections NHS Services Dietary Habits Obesity Prevention Bariatric Surgery Biological Mechanisms Exercise Guidelines Diet Control Natural Remedies Overweight Statistics Surgery Risks Market Trends

Lancet Analysis: Semaglutide Cuts Major Heart Events Regardless of Weight Loss

The finding strengthens the case for prescribing GLP-1 drugs based on cardiovascular risk rather than weight alone.

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

Pilot Study Ties GLP-1 Drugs to Slower Alcohol Absorption and Milder Intoxication

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study

Energy-Reduced Mediterranean Diet Plus Exercise Cuts Type 2 Diabetes Risk by 31%

Colon’s Neurobiotic Sense Detects Bacterial Flagellin to Suppress Appetite

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Weight stigma reduction, not weight loss, key to post-bariatric mental health improvements

Switching to Low-Fat Diet Slows Precancerous Pancreatic Lesions in Obese Mice